Patient (P) No. Gender Age Duration of symptoms Diagnostic test (s) Treatment prior to ocular neostigmine (duration)
P1 M 55y 3 mo ND None
P2 M 37y 1 mo ND None
P3 F 4½ y 5 mo Positive AChR antibody Prednisolone and pyridostigmine (3 mo)
P4 F 48y 5 mo Positive AChR antibody Prednisone (2 mo)
P5 M 27y 3 y ND None
P6 F 47y 1½y Positive AChR antibody Significant decrement on RNS Pyridostigmine (1y)
Abbreviations: AChR: Acetylcholine Receptor; F: Female; M: Male; mo: month; ND: Not Done; RNS: Repetitive Nerve Stimulation; y: years.
Table 1: Clinical features of 6 patients with ocular myasthenia gravis.